disease | Staphylococcal Scalded Skin Syndrome |
smart_toy
bubble_chart Overview Staphylococcal scalded skin syndrome is caused by infection with coagulase-positive group II phage type II Staphylococcus aureus. This bacterium secretes an exfoliative toxin that leads to epidermal detachment, characterized by widespread generalized erythema, flaccid bullae, and extensive epidermal peeling, representing an acute skin disease.
bubble_chart Clinical Manifestations
- No obvious subjective symptoms;
- Sudden onset, often with pustules and a history of upper respiratory tract infection;
- Skin lesions present as flaccid bullae on erythema or large areas of epidermal exfoliation, resembling a scalded appearance, with possible radial rhagade around the mouth.
bubble_chart Diagnosis
- It commonly occurs in infants aged 1 to 5 weeks;
- often accompanied by systemic symptoms such as fever, and is prone to secondary complications like bronchopneumonia and sepsis.
- Coagulase-positive Staphylococcus aureus can be cultured, belonging to bacteriophage group II type 71.
bubble_chart Treatment Measures
Treatment Principles
- For children with simple staphylococcal scalded skin syndrome, the primary focus is on anti-infective therapy;
- for children with complications, attention should be paid to correcting the complications and strengthening supportive treatment.
Medication Principles
- For children with simple staphylococcal scalded skin syndrome, the primary focus is on anti-infective therapy;
- for children with complications, attention should be paid to correcting the complications and strengthening supportive treatment.